Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebron Harrison

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Annals of Surgery|July 22, 2022
Ten-Year Survival and Recurrence Patterns After Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the EsophagusNasser Altorki, Nathan Mynard, Abu Nasar, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 5, 2023
Should sampling of three N2 stations be a quality metric for curative resection of stage I lung cancer?Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 27, 2018
Are minimum volume standards appropriate for lung and esophageal surgery?Sebron Harrison, Virginia Tangel, Xian Wu, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 26, 2022
Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non-small cell lung cancer: Results from a randomized trialBenjamin Lee, Nathan Mynard, Abu Nasar, et al.
The Annals of Thoracic Surgery|February 19, 2022
Extent of Resection Influences Survival in Early-Stage Lung Cancer With Occult Nodal DiseaseNathan Mynard, Abu Nasar, Mohamed Rahouma, et al.
Cell Reports|April 6, 2022
Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinomaNasser K Altorki, Alain C Borczuk, Sebron Harrison, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 12, 2025
All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancerShaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 15, 2017
Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results databaseMohamed Rahouma, Mohamed Kamel, Navneet Narula, et al.
Research Communications in Molecular Pathology and Pharmacology|November 3, 2007
Frequency distribution of cytochrome P450 3A4 gene polymorphism in ethnic populations and in transplant recipientsXinchun Zhou, W Henry Barber, Charles K Moore, et al.
The Annals of Thoracic Surgery|December 26, 2017
Predictors of Survival After Treatment of Oligometastases After EsophagectomyGalal Ghaly, Sebron Harrison, Mohamed K Kamel, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Annals of Surgery|July 22, 2022
Ten-Year Survival and Recurrence Patterns After Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the EsophagusNasser Altorki, Nathan Mynard, Abu Nasar, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 5, 2023
Should sampling of three N2 stations be a quality metric for curative resection of stage I lung cancer?Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 27, 2018
Are minimum volume standards appropriate for lung and esophageal surgery?Sebron Harrison, Virginia Tangel, Xian Wu, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 26, 2022
Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non-small cell lung cancer: Results from a randomized trialBenjamin Lee, Nathan Mynard, Abu Nasar, et al.
The Annals of Thoracic Surgery|February 19, 2022
Extent of Resection Influences Survival in Early-Stage Lung Cancer With Occult Nodal DiseaseNathan Mynard, Abu Nasar, Mohamed Rahouma, et al.
Cell Reports|April 6, 2022
Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinomaNasser K Altorki, Alain C Borczuk, Sebron Harrison, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 12, 2025
All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancerShaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 15, 2017
Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results databaseMohamed Rahouma, Mohamed Kamel, Navneet Narula, et al.
Research Communications in Molecular Pathology and Pharmacology|November 3, 2007
Frequency distribution of cytochrome P450 3A4 gene polymorphism in ethnic populations and in transplant recipientsXinchun Zhou, W Henry Barber, Charles K Moore, et al.
The Annals of Thoracic Surgery|December 26, 2017
Predictors of Survival After Treatment of Oligometastases After EsophagectomyGalal Ghaly, Sebron Harrison, Mohamed K Kamel, et al.
Pageof 5